Animal Models and "omics" Technologies for Identification of Novel Biomarkers and Drug Targets to Prevent Heart Failure

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Hou, Yunlong ^a   Adrian Segarra, Juan M ^a   Richter, Manfred ^b   Kubin, Natalia ^a   Shin, Jaeyoung ^a   Werner, Isabella ^c   Walther, Thomas ^b   Schönburg, Markus ^b   Pöling, Jochen ^a,d   Warnecke, Henning ^d,e   Braun, Thomas ^a   Kostin, Sawa ^a   Kubin, Thomas ^a  

^a MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^b KERCKHOFF HEART CENTER   (Germany)

^c GOETHE UNIVERSITY   (Germany)

^d Department of Cardiac Surgery   (Germany)

^e UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACTININ; BIOLOGICAL MARKER; EZRIN; PROTEOME; TRANSCRIPTOME;

ANIMAL CELL; ANIMAL MODEL; CONTROLLED STUDY; DNA MICROARRAY; HEART DISEASE; HEART FAILURE; HUMAN; HUMAN GENOME; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIMARY CULTURE; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; ANIMAL; DISEASE MODEL; METABOLISM; METABOLOMICS; PRECLINICAL STUDY; PROTEOMICS;

ANIMALIA;

ANIMALS; BIOMARKERS; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; HEART FAILURE; HUMANS; METABOLOMICS; PROTEOMICS;

EID: 84937681227     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/212910     Document Type: Review

References (39)

1. R. Fagard, "Athlete's heart, " Heart, vol. 89, no. 12, pp. 1455-1461, 2003.
2. A. Mesa, C. Jessurun, A. Hernandez et al., "Left ventricular diastolic function in normal human pregnancy, " Circulation, vol. 99, no. 4, pp. 511-517, 1999.
3. M. Szibor, J. Pöling, H. Warnecke, T. Kubin, and T. Braun, "Remodeling and dedifferentiation of adult cardiomyocytes during disease and regeneration, " Cellular and Molecular Life Sciences, vol. 71, no. 10, pp. 1907-1916, 2014.
4. S.Hein and J. Schaper, "Pathogenesis of dilated cardiomyopathy and heart failure: insights from cell morphology and biology, " Current Opinion in Cardiology, vol. 11, no. 3, pp. 293-301, 1996.
5. S. Hein and J. Schaper, "The extracellular matrix in normal and diseasedmyocardium, " Journal of Nuclear Cardiology, vol. 8, no. 2, pp. 188-196, 2001.
6. T. Kubin, J. Poling, S. Kostin et al., "Oncostatin M is a major mediator of cardiomyocyte dedifferentiation and remodeling, " Cell Stem Cell, vol. 9, no. 5, pp. 420-432, 2011.
7. M. Rajabi, C. Kassiotis, P. Razeghi, and H. Taegtmeyer, "Return to the fetal gene program protects the stressed heart: a strong hypothesis, " Heart Failure Reviews, vol. 12, no. 3-4, pp. 331-343, 2007.
8. S. Hein, E. Arnon, S. Kostin et al., "Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms, " Circulation, vol. 107, no. 7, pp. 984-991, 2003.
9. S. Hein, T. Block, R. Zimmermann et al., "Deposition of nonsarcomeric alpha-actinin in cardiomyocytes from patients with dilated cardiomyopathy or chronic pressure overload, " Experimental & Clinical Cardiology, vol. 14, no. 3, pp. e68-e75, 2009.
10. S. Heymans, E. Hirsch, S. D. Anker et al., "Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology, " European Journal of Heart Failure, vol. 11, no. 2, pp. 119-129, 2009.
11. S. Hein, A. Elsässer, S. Kostin, R. Zimmermann, and J. Schaper, "Functional disturbances due to structural remodeling in the failing human heart, " Archives des Maladies du Coeur et des Vaisseaux, vol. 95, no. 9, pp. 815-820, 2002.
12. S. Hein, D. Scholz, N. Fujitani et al., "Altered expression of titin and contractile proteins in failing humanmyocardium, " Journal of Molecular and Cellular Cardiology, vol. 26, no. 10, pp. 1291-1306, 1994.
13. A. Heling, R. Zimmermann, S. Kostin et al., "Increased expression of cytoskeletal, linkage, and extracellular proteins in failing human myocardium, " Circulation Research, vol. 86, no. 8, pp. 846-853, 2000.
14. J. Pöling, P. Gajawada, H. Lörchner et al., "The Janus face of OSM-mediated cardiomyocyte dedifferentiation during cardiac repair and disease, " Cell Cycle, vol. 11, no. 3, pp. 439-445, 2012.
15. J. Pöling, P. Gajawada, M. Richter et al., "Therapeutic targeting of the oncostatin M receptor-β prevents inflammatory heart failure, " Basic Research in Cardiology, vol. 109, no. 1, article 396, 2014.
16. J. Schaper, R. Froede, S. Hein et al., "Impairment of the myocardial ultrastructure and changes of the cytoskeleton in dilated cardiomyopathy, " Circulation, vol. 83, no. 2, pp. 504-514, 1991.
17. J. Schaper, S. Kostin, S. Hein, A. Elsässer, E. Arnon, and R. Zimmermann, "Structural remodelling in heart failure, " Experimental and Clinical Cardiology, vol. 7, no. 2-3, pp. 64-68, 2002.
18. J. N. Cohn, R. Ferrari, and N. Sharpe, "Cardiac remodelingconcepts and clinical implications: a consensus paper from an International Forum on Cardiac Remodeling, " Journal of the American College of Cardiology, vol. 35, no. 3, pp. 569-582, 2000.
19. J. R. Goldsmith and C. Jobin, "Think small: zebrafish as a model system of human pathology, " Journal of Biomedicine and Biotechnology, vol. 2012, Article ID 817341, 12 pages, 2012.
20. C. Zaragoza, C. Gomez-Guerrero, J. L. Martin-Ventura et al., "Animal models of cardiovascular diseases, " Journal of Biomedicine Biotechnology, vol. 2011, Article ID 497841, 13 pages, 2011.
21. J. A. Hill and E. N. Olson, "Cardiac plasticity, " The New England Journal of Medicine, vol. 358, no. 13, pp. 1326-1380, 2008.
22. A.C.deAlmeida, R. J. vanOort, andX.H.Wehrens, "Transverse aortic constriction in mice, " Journal of Visualized Experiments, vol. 38, Article ID e1729, 2010.
23. J. Schaper, S. Hein, D. Scholz, and H. Mollnau, "Multifaceted morphological alterations are present in the failing human heart, " Journal of Molecular and Cellular Cardiology, vol. 27, no. 3, pp. 857-861, 1995.
24. P. E. Kolattukudy, T. Quach, S. Bergese et al., "Myocarditis induced by targeted expression of the MCP-1 gene in murine cardiacmuscle, " The American Journal of Pathology, vol. 152, no. 1, pp. 101-111, 1998.
25. D. L.Mann, "Mechanisms and models in heart failure: a combinatorial approach, " Circulation, vol. 100, no. 9, pp. 999-1008, 1999.
26. Y. Seino, U. Ikeda, H. Sekiguchi et al., "Expression of leukocyte chemotactic cytokines inmyocardial tissue, " Cytokine, vol. 7, no. 3, pp. 301-304, 1995.
27. S. Apostolakis, G. Y. H. Lip, and E. Shantsila, "Monocytes in heart failure: relationship to a deteriorating immune overreaction or a desperate attempt for tissue repair?" Cardiovascular Research, vol. 85, no. 4, pp. 649-660, 2010.
28. A.Martire, B. Fernandez, A. Buehler et al., "Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice mimics ischemic preconditioning through SAPK/JNK1/2 activation, " Cardiovascular Research, vol. 57, no. 2, pp. 523-534, 2003.
29. A. V. Edwards, M. Y.White, and S. J. Cordwell, "The role of proteomics in clinical cardiovascular biomarker discovery, " Molecular and Cellular Proteomics, vol. 7, no. 10, pp. 1824-1837, 2008.
30. D. Gruson, T. Lepoutre, J.-M. Ketelslegers, J. Cumps, S. A. Ahn, and M. F. Rousseau, "C-terminal FGF23 is a strong predictor of survival in systolic heart failure, " Peptides, vol. 37, no. 2, pp. 258-262, 2012.
31. M. Richter, V. Polyakova, G. Gajawada et al., "Oncostatin M induces FGF23 expression in cardiomyocytes, " Journal of Clinical & Experimental Cardiology, 2012.
32. M. J. Damasiewicz, N. D. Toussaint, and K. R. Polkinghorne, "Fibroblast growth factor 23 in chronic kidney disease: new insights and clinical implications, " Nephrology, vol. 16, no. 3, pp. 261-268, 2011.
33. M. R. Roe and T. J. Griffin, "Gel-free mass spectrometry-based high throughput proteomics: tools for studying biological response of proteins and proteomes, " Proteomics, vol. 6, no. 17, pp. 4678-4687, 2006.
34. M.Wiltgen and G. P. Tilz, "DNA microarray analysis: principles and clinical impact, " Hematology, vol. 12, no. 4, pp. 271-287, 2007.
35. X.Qian, Y. Ba, Q.Zhuang, andG.Zhong, "RNA-seq technology and its application in fish transcriptomics, "OMICS: A Journal of Integrative Biology, vol. 18, no. 2, pp. 98-110, 2014.
36. S. Tsukita and S. Yonemura, "ERMproteins: head-to-tail regulation of actin-plasmamembrane interaction, " Trends in Biochemical Sciences, vol. 22, no. 2, pp. 53-58, 1997.
37. H. Ando, T. Kubin, W. Schaper, and J. Schaper, "Cardiac microvascular endothelial cells express α-smooth muscle actin and show low NOS III activity, " The American Journal of Physiology-Heart and Circulatory Physiology, vol. 276, no. 5, pp. H1755-H1768, 1999.
38. H. M. Piper, "Adult ventricular rat heart muscle cells, " in Cell Culture Techniques in Heart and Vessel Research, pp. 36-60, Springer, Berlin, Germany, 1990.
39. D. M. Kaye and H. Krum, "Drug discovery for heart failure: a new era or the end of the pipeline?" Nature Reviews Drug Discovery, vol. 6, no. 2, pp. 127-139, 2007.